Skip to main content navigation
Site logo
[n]
Not signed in
Sign in

Powered by Sitebuilder
© MMVIII  |  Privacy

Re-Designing Designer Drugs to Stop Cancer - Transcript

[c]

00.00            Exterior Medical School
                      CU Sign
                      CU Lymph cell bottle
                      Ws researcher at microscope
                      Tilt up to samples                                                  

Guide Voice: A discovery by researchers at the University of Birmingham may bring new hope to the 10,000 people in the UK alone, who are diagnosed with a Lymphoma – cancer of the white blood cells, each year.

Beginning with the premise that the brain and the immune system actually talk to one another, they started researching whether chemicals known to affect the brain, could have an impact on the immune system and the cancers that arise from it.

00.22 SOT Professor John Gordon, Medical School, University of Birmingham -“It really started, this whole study on showing that these cancer cells of the immune system, the lymphoma cells, responded and took up the chemical known as Serotonin. This is the happy hormone, the one that keeps us happy. We were a bit surprised that the cancer cells in the blood should be doing that as well, but knowing that it meant we have potential drugs that could act as therapy perhaps in killing or stopping these lymphoma cells from growing, so that’s when we started to test the different ones that are out there, that work in this system.”

00.58            Tilt down ‘scope
                      CU samples BCU samples

Backed by the Leukaemia Research Fund, researchers began testing various drugs like anti- depressants and amphetamine derivatives and measuring their impact on cancerous cells.

01.08 SOT Dr Nick Barnes, Reader in Neuropharmacology - “We have been taking cell lines, which are representative of lymphomas, and then we’ve been adding various drugs which target proteins to seratonin, recognising seratonin. And we’ve been identifying whether these drugs can actually stop the tumour cells from dividing, from growing.” 

01.24 SOT Professor John Gordon - “What we found was among a wide range of different types of Lymphoma that we grow in a test tube, MDMA, which most people know as ecstasy, can actually stop the cells growing. Now that builds on previous studies that we’ve done on Prozac- Prozac seems to do pretty much the same thing. So now we’re finding 2 drugs that are having the same effect and that will give us really good clues as to how they’re working.”

01.51            Lymph cells pipette
                      Pan to samples
                      John pippetting
                      Nick at ‘scope        

Guide Voice: In over half of the 17 Lymphoma samples studied growth stopped or was significantly slowed by the various drugs including the amphetamine derivatives. Of the drugs investigated, the discovery of Prozac’s impact on cancer cells is likely to have the most immediate impact, because it has already been extensively tested and has a good safety record.

02.12 SOT Professor John Gordon - “We’re talking to people about getting the Prozac into formal clinical trials, so hopefully with the right funding behind us we’ll be able to test whether what we see in the test tube really works in patients, because of course that is our ultimate goal.” 

02.28            CU pipette & samples

Guide Voice: The applications of the Ecstasy discovery are not so straightforward as it was tested in liquid form in strong doses…    

02.37 Dr Nick Barnes - “The concentrations of Ecstasy required are far too high to use in the patient, indeed they would almost immediately kill the patient, however if we can tease apart the mechanism of action for the ecstasy to stop the tumour cells from growing, away from the psychotropic actions of ecstasy, which is why people abuse the drug, then we may be able to identify a more appropriate drug to stop the lymphoid tissue."

03.02            Petrie dishes & Scope

Guide Voice: The next stage of the research into Ecstasy is to actually identify how it is causing these cells to stop growing.

03.09 SOT Professor John Gordon - “We need to really understand the mechanism. So we need to probe deeper into how these drugs are killing the cells, and then possibly with the example of MDMA/Ecstasy, by re-designing that designer drug, we might have an effective therapy for at least some of these patients.”

Ends            03’ 28”

03.31            Additional Material

(Researcher takes samples from scope, Pull focus samples, samples in light) 

Page contact: Shuehyen Wong Last revised: Thu 5 May 2005
Back to top of page